Summary:
Click image to enlarge
Join Our Clinical Trial for Eosinophilic Asthma Treatment
We’re seeking participants for a clinical trial testing a new treatment administered subcutaneously (SC) every 4 weeks for the first 3 doses, then every 8 weeks. This treatment is for individuals with Eosinophilic asthma who remain uncontrolled on Medium-dose ICS-LABA therapy, with or without other controllers (excluding oral steroids).
Qualified Participants Must:
• 12-75 years of age at the time of study
•
Weight of ≥ 35 kg
•
You must have a doctor-diagnosed history of Asthma that has required treatment with medium-dose inhaled corticosteroids (ICS) and a long-acting beta agonist (LABA) for at least 12 months before your first clinic visit
•
Peripheral blood Eosinophil count of ≥ 150 cells/μL assessed by local laboratory prior to study visit
Qualified Participants May Receive:
- Compensation: Get compensated up to $80 per clinic visit with no cost to you or your insurance!
- Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.
- No-cost study medications: Study medications for Eosinophilic Asthma are given at no cost